Abstract 3972: Comprehensive immune landscape analysis of solid tumors using a 17-Plex immunofluorescence assay in clinical trialsJaspreet Kaur, Jennifer Bordeaux, Lisa Kattenhorn et al.|Cancer Research|2026Cited by 0
Abstract 3099: Selective CDK2 inhibition with ECI830: preclinical characterization, efficacy, and on-target mechanism supported by biomarker and gene signature analysisOphélia Maertens, Samuel B. Ho, Bradley French et al.|Cancer Research|2026Cited by 0